BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 22, 2015
View Archived Issues
Osaka University starts phase I/II trial of CNT-01 in patients with idiopathic TGCV
Read More
Tohoku University, Gunma University and Fuso disclose OPN production inhibitors
Read More
Glycemic improvements similar with omarigliptin and sitagliptin in patients with type 2 diabetes
Read More
Pediatric schistosomiasis candidate L-praziquantel safe in phase I study in healthy volunteers
Read More
New mutation in HNF1B identified in patient with maturity-onset diabetes of the young type 5
Read More
Rat forelimb allotransplantation model enables assessment of function
Read More
FDA grants fast track designation to Alcobra's metadoxine extended release
Read More
Transgenic pigs used to model gestational diabetes
Read More
Glide Technologies and Cilian to develop novel solid dose recombinant influenza vaccine
Read More
Palatin Technologies and Richter terminate license agreement for bremelanotide
Read More
Saniona reports data supporting the use of Tesomet in type 2 diabetes, plans proof-of-concept study
Read More
Artificially designed peptide inhibits HIV fusion with improved pharmacological properties
Read More
AcelRx sells portion of Zalviso royalty stream to PDL BioPharma
Read More
Phase III induction trials of tofacitinib in ulcerative colitis meet primary endpoints
Read More
Companies receive funding to advance Ebola programs
Read More
Harbour Antibodies signs new licenses to transgenic mouse platforms
Read More
Roche reports compounds for the treatment of hepatitis B
Read More
Gilead reports topline results from four phase III studies of sofosbuvir/velpatasvir for HCV
Read More
Aerie initiates phase III trial of Roclatan
Read More
Akari Therapeutics formed to develop treatments for diseases involving complement C5
Read More
Plexxikon discloses c-Kit inhibitors
Read More
Clinical effect of K-877 may be superior to fibrate drugs on the market
Read More
Taro launches Keveyis for primary hyperkalemic and hypokalemic periodic paralysis
Read More
Pharmaxis reports phase I results for PXS-4728A
Read More
LFB's IVIg Iqymune approved in U.K. and Denmark
Read More